REGN

Regeneron Pharmaceuticals, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$951.19

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %3.2 / %30

Non-compliant assets / Total market cap %17.7 / %30

Non-compliant revenue / Total income %4.2 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions.

Website

Analysis (Turkish): REGN Hissesi Caiz mi, Helal mi? Regeneron Pharmaceuticals, Inc. Katılım Analizi